Publication | Closed Access

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study

Phase Ib StudyOncologyMedicineCancer Cell BiologyBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyMolecular Oncology